Metabolic syndrome

Journal of Atherosclerosis and Thrombosis

Volumn 15, Issue 1, 2008, Pages 1-5

  Teramoto, Tamio ^a   Sasaki, Jun ^a   Ueshima, Hirotsugu ^a   Egusa, Genshi ^a   Kinoshita, Makoto ^a   Shimamoto, Kazuaki ^a   Daida, Hiroyuki ^a   Biro, Sadatoshi ^a   Hirobe, Kazuhiko ^a   Funahashi, Tohru ^a   Yokote, Koutaro ^a   Yokode, Masayuki ^a  

^a Committee for Epidemiology and Clinical Management of Atherosclerosis ^*

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD; HUMAN; JAPAN; LIFESTYLE; METABOLIC SYNDROME X; REVIEW; RISK FACTOR;

CHOLESTEROL, LDL; HUMANS; JAPAN; LIFE STYLE; METABOLIC SYNDROME X; RISK FACTORS;

EID: 45149116302     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E580     Document Type: Article

References (23)

1. Ministry of Health, Labour and Welfare: Kokuminkenkou-eiyouchousahoukoku, 2006 (in Japanese)
2. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 1988; 37:1595-1607
3. Kaplan NM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med, 1989; 149:1514-1520
4. Fujioka S, Matsuzawa Y, Tokunaga K, and Tarui S: Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism, 1987; 36:54-59
5. DeFronzo RA and Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 1991; 14:173-194
6. World Hearth Organization Definition, diagnosis, and classification of diabetes and its complications: report of a WHO consultation. Part I: World Hearth Organization, 1999
7. Nihon Naikagakkai Zassi, 2005; 94:188-203 (in Japanese)
8. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group: The metabolic syndrome- a new worldwide definition. Lancet, 2005; 366:1059-1062
9. Roudoushousagyoukanrensikkansougoutaisakukenkyu, 1994 (in Japanese)
10. Nakamura T, Tsubono Y, Kameda-Takemura K, Funahashi T. Yamashita S, Hisamichi S, Kita T, Yamamura T, and Matsuzawa Y; Group of the Research for the Association between Host Origin and Atherosclerotic Diseases under the Preventive Measure for Work-related Diseases of the Japanese Labor Ministry; Origin and Atherosclerotic Diseases under the Preventive Measure for Work-related Diseases of the Japanese Labor Ministry: Magnitude of sustained multiple risk factors for ischemic heart disease in Japanese employees: a casecontrol study. Circ J, 2001; 65:11-17
11. Nakamura Y, Yamamoto T, Okamura T, Kadowaki T, Hayakawa T, Kita Y, Saitoh S, Okayama A, and Ueshima H; The NIPPON DATA80 Research Group: Combined Cardiovascular Risk Factors and Outcome-NIPPON DATA80, 1980-1994. Circ J, 2006; 70:960-964
12. Okubo K and Kiyohara Y: Rinshoutokenkyu, 2004; 81:1736-1740 (in Japanese)
13. Roudoushoukenkoukagakusougoukenyuzigyouhoukoku, 2001 (in Japanese)
14. Journal of Japan Society for the Study of Obesity, 2000; 6:18-28 (in Japanese)
15. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity: New criteria for 'obesity disease' in Japan. Circ J, 2002; 66:987-992
16. Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K, Islam AH, Keno Y, Kobatake T, and Nagai Y: Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis, 1994; 107:239-248
17. Fujimoto WY, Bergstrom RW, Boyko EJ, Chen KW, Leonetti DL, Newell-Morris L, Shofer JB, and Wahl PW: Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care, 1999; 22:1808-1812
18. Takeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohhata J, Isobe T, and Shimamoto K: Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study. Hypertens Res, 2005; 28:203-208
19. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, and Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004; 110:1245-1250
20. Hunt KJ, Resendez RG, Williams K, Haffher SM, and Stern MP; San Antonio Heart Study: National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation, 2004; 110:1251-1257
21. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, and Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001; 24:683-689
22. Lakka. HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, and Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA, 2002; 288:2709-2716
23. Kasai T, Miyauchi K, Kurata T, Ohta H, Okazaki S, Miyazaki T, Kajimoto K, Kubota N, and Daida H: Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention. Circ J, 2006; 70:1531-1537